CH25H and laryngotracheoesophageal cleft: However, no significant decrease in the CH25H expression was observed in LUSC patients with tumor metastasis (P > 0.05, Fig. 5B), indicating that the CH25H expression level is a potential biomarker for LC metastasis prediction, especially in LUAD.